Guidelines. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease.
Pulmonary hypertension (PH) due to left heart disease is the most common cause of pulmonary hypertension in the western world. It is classified as WHO PH group II. Different pathophysiologic abnormalities may take place in this condition, including pulmonary venous congestion and vascular remodeling...
| Publicado en: | Annals of Thoracic Medicine Vol. 9; no. S1; pp. 47 - 56 |
|---|---|
| Autores principales: | , , , |
| Formato: | review tables/charts Journal Article |
| Publicado: |
Wolters Kluwer India Pvt Ltd
Jul-Sep2014 Supplement 1
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=103963933&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 103963933 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 18171737 259D jtl: Annals of Thoracic Medicine issn: 18171737 maglogo: N pubinfo: dt: Jul-Sep2014 Supplement 1 vid: 9 iid: S1 pid: 16919 pub: Wolters Kluwer India Pvt Ltd artinfo: ui: 103963933 96641339 10.4103/1817-1737.134026 103963933 ppf: 47 ppct: 9 formats: tig: atl: Guidelines. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary hypertension due to left heart disease. aug: au: Alhabeeb, Waleed Idrees, Majdy M. Ghio, Stefano Kashour, Tarek affil: Department of Cardiology, King Faisal Specialist Hospital and Research Center, Riyadh sug: subj: Hypertension, Pulmonary Diagnosis Hypertension, Pulmonary Therapy Practice Guidelines Saudi Arabia Heart Diseases Classification ab: Pulmonary hypertension (PH) due to left heart disease is the most common cause of pulmonary hypertension in the western world. It is classified as WHO PH group II. Different pathophysiologic abnormalities may take place in this condition, including pulmonary venous congestion and vascular remodeling. Despite the high prevalence of WHO group 2 PH, the major focus of research on PH over the past decade has been on WHO group 1 pulmonary arterial hypertension (PAH). Few investigators have focused on WHO group 2 PH; consequently, the pathophysiology of this condition remains poorly understood, and no specific therapy is available. Clinical and translational studies in this area are much needed and have the potential to positively affect large numbers of patients. In this review, we provide a detailed discussion upon the pathophysiology of the disease, the recent updates in classification, and the diagnostic and therapeutic algorithms. pubtype: Academic Journal doctype: review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|